{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:27:46Z","timestamp":1794889666613,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaad.2025.02.066","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T02:56:02Z","timestamp":1740452162000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Early initiation of hydroxychloroquine in cutaneous lupus erythematosus to prevent progression to systemic lupus erythematosus: A long-term follow-up study"],"prefix":"10.1016","volume":"93","author":[{"given":"Danielle","family":"Bar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Druyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2025.02.066_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.abd.2022.09.005","article-title":"Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects","volume":"98","author":"Vale","year":"2023","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.066_bib2","first-page":"330","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Bucur)"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.02.066_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866319","article-title":"A systematic review of the progression of cutaneous lupus to systemic lupus erythematosus","volume":"13","author":"Curtiss","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jaad.2025.02.066_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/1744666X.2020.1805316","article-title":"New insights into the progression from cutaneous lupus to systemic lupus erythematosus","volume":"16","author":"Zhou","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/jid.2014.316","article-title":"From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013","volume":"135","author":"Schultz","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.066_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jid.2018.08.017","article-title":"Advances in cutaneous lupus erythematosus and dermatomyositis: a report from the 4th International Conference on Cutaneous Lupus Erythematosus-an ongoing need for International Consensus and Collaborations","volume":"139","author":"Concha","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.02.066_bib8","first-page":"545","article-title":"Trends in the outpatient medication management of lupus erythematosus in the United States","volume":"13","author":"Sugai","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.066_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clindermatol.2018.04.002","article-title":"Cutaneous lupus erythematosus: reflecting on practice-changing observations over the past 50 years","volume":"36","author":"Callen","year":"2018","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-0172(78)90033-1","article-title":"Antimalarials in the management of discoid and systemic lupus erythematosus","volume":"8","author":"Dubois","year":"1978","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjd.15312","article-title":"Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis","volume":"177","author":"Chasset","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.066_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jaad.2025.02.066_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0961203307086503","article-title":"Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival","volume":"17","author":"Sis\u00f3","year":"2008","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.066_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jaad.2025.02.066_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2025.02.066_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102707","article-title":"Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus","volume":"123","author":"Lu","year":"2021","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.066_bib18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/bjd.20597","article-title":"British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021","volume":"185","author":"O'Kane","year":"2021","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.02.066_bib19","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaad.2025.02.066_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.066_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.066_bib22","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jisp.2016.09.001","article-title":"Not just skin deep: systemic disease involvement in patients with cutaneous lupus","volume":"18","author":"O'Brien","year":"2017","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.066_bib23","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaad.2024.01.041","article-title":"Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: a monocentric study of 149 patients","volume":"90","author":"Masseran","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.066_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaad.2022.09.028","article-title":"Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients","volume":"88","author":"Fredeau","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"10.1016\/j.jaad.2025.02.066_bib25","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.066_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2010.435","article-title":"Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus","volume":"147","author":"Klein","year":"2011","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.02.066_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.jaad.2025.02.066_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.120157","article-title":"Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus","volume":"40","author":"Broder","year":"2013","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.066_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001317","article-title":"Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA","volume":"11","author":"Figueroa-Parra","year":"2024","journal-title":"Lupus Sci Med"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.066_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.066_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/ker368","article-title":"Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort","volume":"51","author":"Lopez","year":"2012","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:46:09Z","timestamp":1766112369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225003615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0190962225003615"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.066","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early initiation of hydroxychloroquine in cutaneous lupus erythematosus to prevent progression to systemic lupus erythematosus: A long-term follow-up study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}